awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
Graphs
1
Q42770014-CD1B2EFA-4E5F-44E4-8B38-301594BA0ED5
Q42770014-CD1B2EFA-4E5F-44E4-8B38-301594BA0ED5
BestRank
Statement
http://www.wikidata.org/entity/statement/Q42770014-CD1B2EFA-4E5F-44E4-8B38-301594BA0ED5
Predictors of response after intravitreal bevacizumab injection for neovascular age-related macular degeneration.
P2860
Q42770014-CD1B2EFA-4E5F-44E4-8B38-301594BA0ED5
BestRank
Statement
http://www.wikidata.org/entity/statement/Q42770014-CD1B2EFA-4E5F-44E4-8B38-301594BA0ED5
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
87e777e595d6c66aea75fb1faf4b0df5b5625c7a
P2860
Comparative study of intravitreal bevacizumab (Avastin) versus ranibizumab (Lucentis) in the treatment of neovascular age-related macular degeneration.